| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Chisom Adaobi Nri-Ezedi, Thomas Ulasi, Chilota Chibuife Efobi, John Chinawaeze Aneke, Nwanneka Ugwu, Chinekwu Nwos. Bloodless management of significantly elevated transcranial Doppler velocity value in a Jehovah's witness child with sickle cell disease: A tertiary centre experience-A case report. Journal of the National Medical Association. 2024-02-03. PMID:38310045. |
effective management of complications in sickle cell disease (scd), such as stroke prevention, often necessitates the use of blood transfusions. |
2024-02-03 |
2024-02-06 |
Not clear |
| Wolney de Oliveira Taques, Gabriele Curvo Bett, Bárbara Lucia Barbosa de Moraes, Iasmin Medeiros, Cor Jesus Fernandes Fontes, Ruberlei Godinho de Oliveir. Factors Associated with Overt Stroke in Children and Adolescents with Sickle Cell Disease: A Retrospective Cohort Study. Hemoglobin. 2024-01-24. PMID:38263710. |
sickle cell disease (scd) is associated with a high occurrence of complications due to vaso-occlusive phenomenon such as stroke. |
2024-01-24 |
2024-01-26 |
Not clear |
| Wolney de Oliveira Taques, Gabriele Curvo Bett, Bárbara Lucia Barbosa de Moraes, Iasmin Medeiros, Cor Jesus Fernandes Fontes, Ruberlei Godinho de Oliveir. Factors Associated with Overt Stroke in Children and Adolescents with Sickle Cell Disease: A Retrospective Cohort Study. Hemoglobin. 2024-01-24. PMID:38263710. |
this retrospective cohort study aimed to examine the clinical and laboratory characteristics of 120 children and adolescents with scd and analyze the factors associated with overt stroke incidence. |
2024-01-24 |
2024-01-26 |
Not clear |
| Wolney de Oliveira Taques, Gabriele Curvo Bett, Bárbara Lucia Barbosa de Moraes, Iasmin Medeiros, Cor Jesus Fernandes Fontes, Ruberlei Godinho de Oliveir. Factors Associated with Overt Stroke in Children and Adolescents with Sickle Cell Disease: A Retrospective Cohort Study. Hemoglobin. 2024-01-24. PMID:38263710. |
in conclusion, a history of a high number of dactylitis, acs/pneumonia, increased rdw, and reticulocytosis was associated with overt stroke occurrence in children and adolescents with scd. |
2024-01-24 |
2024-01-26 |
Not clear |
| Natalie Booth, Alexander Ngwube, Brian Appavu, Sanjay Shah, Todd Abruzz. Reversal of Cerebral Arteriopathy Post-Hematopoietic Stem Cell Transplant for Sickle Cell Disease. Pediatrics. 2024-01-24. PMID:38263886. |
as a result, arterial ischemic stroke is a major cause of morbidity and mortality in scd, and scd is a leading cause of childhood stroke worldwide. |
2024-01-24 |
2024-01-26 |
Not clear |
| Candice J Adams-Mitchell, Wally R Smith, Diana J Wilki. Dysphagia in patients with sickle cell disease: An understudied problem. Journal of the National Medical Association. 2024-01-23. PMID:38262892. |
strokes are a potentially devastating complication of sickle cell disease (scd), the most common genetic hemoglobinopathy worldwide, yet little is known about dysphagia as it relates to scd. |
2024-01-23 |
2024-01-26 |
Not clear |
| Faisal Hakami, Essam Alhazmi, Wafa M Busayli, Sultan Althurwi, Abdulrahman M Darraj, Mohammed A Alamir, Alyaj Hakami, Renad A Othman, Amal I Moafa, Hassan A Mahasi, Mohammed Ali Madkhal. Overview of the Association Between the Pathophysiology, Types, and Management of Sickle Cell Disease and Stroke. Cureus. vol 15. issue 12. 2023-12-19. PMID:38107212. |
sickle cell disease (scd) is a genetic blood disorder that affects hemoglobin and increases stroke risk, particularly in childhood. |
2023-12-19 |
2023-12-21 |
Not clear |
| Faisal Hakami, Essam Alhazmi, Wafa M Busayli, Sultan Althurwi, Abdulrahman M Darraj, Mohammed A Alamir, Alyaj Hakami, Renad A Othman, Amal I Moafa, Hassan A Mahasi, Mohammed Ali Madkhal. Overview of the Association Between the Pathophysiology, Types, and Management of Sickle Cell Disease and Stroke. Cureus. vol 15. issue 12. 2023-12-19. PMID:38107212. |
this review examines the pathophysiological association between scd and stroke, the classification of stroke types, risk factors, diagnosis, management, prevention, and prognosis. |
2023-12-19 |
2023-12-21 |
Not clear |
| Faisal Hakami, Essam Alhazmi, Wafa M Busayli, Sultan Althurwi, Abdulrahman M Darraj, Mohammed A Alamir, Alyaj Hakami, Renad A Othman, Amal I Moafa, Hassan A Mahasi, Mohammed Ali Madkhal. Overview of the Association Between the Pathophysiology, Types, and Management of Sickle Cell Disease and Stroke. Cureus. vol 15. issue 12. 2023-12-19. PMID:38107212. |
relevant studies on scd and stroke pathophysiology, classification, epidemiology, diagnosis, treatment, and prevention were identified. |
2023-12-19 |
2023-12-21 |
Not clear |
| Faisal Hakami, Essam Alhazmi, Wafa M Busayli, Sultan Althurwi, Abdulrahman M Darraj, Mohammed A Alamir, Alyaj Hakami, Renad A Othman, Amal I Moafa, Hassan A Mahasi, Mohammed Ali Madkhal. Overview of the Association Between the Pathophysiology, Types, and Management of Sickle Cell Disease and Stroke. Cureus. vol 15. issue 12. 2023-12-19. PMID:38107212. |
this review synthesizes current evidence on scd and stroke to highlight opportunities for further research and standardizing care protocols across institutions. |
2023-12-19 |
2023-12-21 |
Not clear |
| Adetola A Kassim, Michael R DeBau. The range of haploidentical transplant protocols in sickle cell disease: all haplos are not created equally. Hematology. American Society of Hematology. Education Program. vol 2023. issue 1. 2023-12-09. PMID:38066894. |
the ideal curative therapy for sickle cell disease (scd) must be applicable across all ages and include individuals with strokes and preexisting heart, lung, and kidney disease. |
2023-12-09 |
2023-12-17 |
human |
| Abdalla M Zayed, Sulaiman Al-Muhaimeed, Turki Al-Otaibi, Elsayed Mohammed Ali, Rashid Saleh, Shangrila Joy Ancheta, Fahad Al-Harbi, Khawaja Bilal Waheed, Yasir Albahli, Hamid Alghamd. Moyamoya Syndrome in Children With Sickle Cell Disease in Saudi Arabia: A Single-Center Experience. Cureus. vol 15. issue 11. 2023-12-01. PMID:38024048. |
the target population was children aged six months to 14 years with scd and a history of stroke or transient ischemic attacks (tias). |
2023-12-01 |
2023-12-07 |
Not clear |
| Abdalla M Zayed, Sulaiman Al-Muhaimeed, Turki Al-Otaibi, Elsayed Mohammed Ali, Rashid Saleh, Shangrila Joy Ancheta, Fahad Al-Harbi, Khawaja Bilal Waheed, Yasir Albahli, Hamid Alghamd. Moyamoya Syndrome in Children With Sickle Cell Disease in Saudi Arabia: A Single-Center Experience. Cureus. vol 15. issue 11. 2023-12-01. PMID:38024048. |
conclusion in this study, the prevalence of overt stroke is 9% in children with scd originating from the southwestern region of saudi arabia (26/286), and 61.5% of them (16/26) had mms. |
2023-12-01 |
2023-12-07 |
Not clear |
| Abdalla M Zayed, Sulaiman Al-Muhaimeed, Turki Al-Otaibi, Elsayed Mohammed Ali, Rashid Saleh, Shangrila Joy Ancheta, Fahad Al-Harbi, Khawaja Bilal Waheed, Yasir Albahli, Hamid Alghamd. Moyamoya Syndrome in Children With Sickle Cell Disease in Saudi Arabia: A Single-Center Experience. Cureus. vol 15. issue 11. 2023-12-01. PMID:38024048. |
in places lacking tcd facilities, further studies are required to determine if mra brain screenings of children with scd may detect mms before the onset of stroke and help start protective therapy. |
2023-12-01 |
2023-12-07 |
Not clear |
| Abdalla M Zayed, Sulaiman Al-Muhaimeed, Turki Al-Otaibi, Elsayed Mohammed Ali, Rashid Saleh, Shangrila Joy Ancheta, Fahad Al-Harbi, Khawaja Bilal Waheed, Yasir Albahli, Hamid Alghamd. Moyamoya Syndrome in Children With Sickle Cell Disease in Saudi Arabia: A Single-Center Experience. Cureus. vol 15. issue 11. 2023-12-01. PMID:38024048. |
the target population was children aged six months to 14 years with scd and a history of stroke or transient ischemic attacks (tias). |
2023-11-29 |
2023-12-07 |
Not clear |
| Abdalla M Zayed, Sulaiman Al-Muhaimeed, Turki Al-Otaibi, Elsayed Mohammed Ali, Rashid Saleh, Shangrila Joy Ancheta, Fahad Al-Harbi, Khawaja Bilal Waheed, Yasir Albahli, Hamid Alghamd. Moyamoya Syndrome in Children With Sickle Cell Disease in Saudi Arabia: A Single-Center Experience. Cureus. vol 15. issue 11. 2023-12-01. PMID:38024048. |
conclusion in this study, the prevalence of overt stroke is 9% in children with scd originating from the southwestern region of saudi arabia (26/286), and 61.5% of them (16/26) had mms. |
2023-11-29 |
2023-12-07 |
Not clear |
| Abdalla M Zayed, Sulaiman Al-Muhaimeed, Turki Al-Otaibi, Elsayed Mohammed Ali, Rashid Saleh, Shangrila Joy Ancheta, Fahad Al-Harbi, Khawaja Bilal Waheed, Yasir Albahli, Hamid Alghamd. Moyamoya Syndrome in Children With Sickle Cell Disease in Saudi Arabia: A Single-Center Experience. Cureus. vol 15. issue 11. 2023-12-01. PMID:38024048. |
in places lacking tcd facilities, further studies are required to determine if mra brain screenings of children with scd may detect mms before the onset of stroke and help start protective therapy. |
2023-11-29 |
2023-12-07 |
Not clear |
| Marina García-Morin, Eduardo J Bardón-Cancho, Cristina Beléndez, Elena Dulín, Paula Blanco-Soto, Carolina Puertas-López, Mar Prieto-Medina, Áurea Cervera-Bravo, Lucía Llorente-Otones, Vanesa Pérez-Alonso, Sonsoles San-Román, Cruz Vecilla-Rivelles, Montserrat López-Rubio, Elena Sebastián, José M Bellón, Elena Cel. Madrid Newborn Sickle Cell Disease Cohort: clinical outcomes, stroke prevention and survival. Annals of hematology. 2023-11-18. PMID:37980280. |
the aim of this study is to describe the morbimortality and the stroke prevention programme in patients diagnosed by scd nbs in madrid. |
2023-11-18 |
2023-11-20 |
Not clear |
| Helen Fogarty, Azaz Ahmad, Ferdows Atiq, Dearbhla Doherty, Soracha Ward, Ellie Karampini, Aisling M Rehill, Gemma Leon, Ciara Byrne, Rosena Geoghegan, Helena Conroy, Mary B Byrne, Ulrich Budde, Sonja Schneppenheim, Ciara Sheehan, Noel Ngwenya, Ross Ian Baker, Roger J S Preston, Emma Tuohy, Corrina B McMahon, James S O'Donnel. VWF-ADAMTS13 axis dysfunction in children with sickle cell disease treated with hydroxyurea versus blood transfusion. Blood advances. 2023-09-29. PMID:37773926. |
although blood transfusion is the gold standard for stroke prevention in scd, the biological mechanisms underpinning its improved efficacy compared to hydroxycarbamide are not fully understood. |
2023-09-29 |
2023-10-07 |
Not clear |
| Kristine A Karkoska, Jahnavi Gollamudi, Hyacinth I Hyacint. Molecular and environmental contributors to neurological complications in sickle cell disease. Experimental biology and medicine (Maywood, N.J.). 2023-09-09. PMID:37688519. |
the neurological complications of scd are particularly devastating and diverse, ranging from overt stroke to covert cerebral injury, including silent cerebral infarctions and blood vessel tortuosity. |
2023-09-09 |
2023-10-07 |
Not clear |